Search Within

AMYOTROPHIC LATERAL SCLEROSIS

Protective Effects of the Caffeine Against Neurodegenerative Diseases

Journal: Current Medicinal Chemistry
Volume: 26, Issue: 27
Page: 5137-5151
Authors: Ester Tellone*, Antonio Galtieri, Annamaria Russo and Silvana Ficarra

Applying Auto-Regressive Model’s Yule-Walker Approach to Amyotrophic Lateral Sclerosis (ALS) patients’ Data

Journal: Current Medical Imaging
Volume: 15, Issue: 8
Page: 749-760
Authors: Mridu Sahu*, Saumya Vishwal , Srungaram Usha Srivalli, Naresh Kumar Nagwani, Shrish Verma and Sneha Shukla

Nanoneuromedicines for Neurodegenerative Diseases

Journal: Nanoscience & Nanotechnology-Asia
Volume: 9, Issue: 1
Page: 58-63
Authors: Ram Singh* and Geetanjali

Amyotrophic Lateral Sclerosis and Oxidative Stress: A Double-Blind Therapeutic Trial After Curcumin Supplementation

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 17, Issue: 10
Page: 767-779
Authors: Lucia Chico*, Elena Caldarazzo Ienco, Costanza Bisordi, Annalisa Lo Gerfo, Lucia Petrozzi, Antonio Petrucci, Michelangelo Mancuso and Gabriele Siciliano

Understanding the Role of Hypoxia Inducible Factor During Neurodegeneration for New Therapeutics Opportunities

Journal: Current Neuropharmacology
Volume: 16, Issue: 10
Page: 1484-1498
Authors: Amalia Merelli, Julio César García Rodríguez, Jaume Folch, Marcelo R. Regueiro, Antoni Camins and Alberto Lazarowski*

Determination of Parameters of Oxidative Stress in vitro Models of Neurodegenerative Diseases-A Review

Journal: Current Clinical Pharmacology
Volume: 13, Issue: 2
Page: 100-109
Authors: Chistiane Mendes Feitosa*, George Laylson da Silva Oliveira, Antonio do Nascimento Cavalcante, Soane Kaline Morais Chaves and Mahendra Rai

Update on the Regulation of HIPK1, HIPK2 and HIPK3 Protein Kinases by microRNAs

Journal: MicroRNA
Volume: 7, Issue: 3
Page: 178-186
Authors: Andrea Conte and Giovanna Maria Pierantoni*

Retraction Notice: Potential Application of Venom Proteins in Designing of Medicines for Treating Human Neurodegenerative Disorders

Journal: Protein & Peptide Letters
Volume: 25, Issue: 7
Page: 633-642
Authors: Zahid Rasul Niazi, Naqab Khan, Samiullah Khan, Mehboob Alam and Mohammad Amjad Kamal*

Role of Curcumin in Regulation of TNF-α Mediated Brain Inflammatory Responses

Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 12, Issue: 1
Page: 69-77
Authors: Tirthraj Baj and Rohit Seth*

The Effect of Single and Double Acetylation of Lysine Residues on Structural and Dynamical Features of Human Splicing Factor TDP-43 - A Statistical Ensemble Analysis

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21, Issue: 5
Page: 358-373
Authors: Farahnaz Rezaei Makhouri and Jahan B. Ghasemi*

Emerging Targets and Latest Proteomics Based Therapeutic Approaches in Neurodegenerative Diseases

Journal: Current Protein & Peptide Science
Volume: 19, Issue: 9
Page: 858-875
Authors: Munazza Tamkeen Fatima, Zeyaul Islam, Ejaj Ahmad and Parveen Salahuddin*

Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18, Issue: 4
Page: 565-572
Authors: Marta Kinga Lemieszek*, Andrzej Stepulak, Katarzyna Sawa-Wejksza, Arkadiusz Czerwonka, Chrysanthy Ikonomidou and Wojciech Rzeski

The Role of Inflammation in Neurological Disorders

Journal: Current Pharmaceutical Design
Volume: 24, Issue: 14
Page: 1485-1501
Authors: Diana Degan, Raffaele Ornello, Cindy Tiseo, Antonio Carolei, Simona Sacco and Francesca Pistoia*

Frontier View on Nanotechnological Strategies for Neuro-therapy

Journal: Current Drug Metabolism
Volume: 19, Issue: 7
Page: 596-604
Authors: Asim Azhar, Ghulam Md. Ashraf*, Qamar Zia, Shakeel A. Ansari, Asma Perveen, Abdul Hafeez, Mohd Saeed, Mohammad A. Kamal, Athanasios Alexiou, Magdah Ganash, Nagendra S. Yarla, Saleh S. Baeesa, Mohamed M. Alfiky and Osama S. Bajouh

In Silico Studies in Drug Research Against Neurodegenerative Diseases

Journal: Current Neuropharmacology
Volume: 16, Issue: 6
Page: 664-725
Authors: Farahnaz Rezaei Makhouri and Jahan B. Ghasemi*

Current Therapeutic Molecules and Targets in Neurodegenerative Diseases Based on in silico Drug Design

Journal: Current Neuropharmacology
Volume: 16, Issue: 6
Page: 649-663
Authors: Sheikh Arslan Sehgal*, Mirza A. Hammad, Rana Adnan Tahir, Hafiza Nisha Akram and Faheem Ahmad

Temporal Expression of Mutant TDP-43 Correlates with Early Amyotrophic Lateral Sclerosis Phenotype and Motor Weakness

Journal: Current Neurovascular Research
Volume: 15, Issue: 1
Page: 3-9
Authors: Qihua Chen, Jinxia Zhou, Cao Huang, Bo Huang, Fangfang Bi, Hongxia Zhou* and Bo Xiao*

Decoding Common Features of Neurodegenerative Disorders: From Differentially Expressed Genes to Pathways

Journal: Current Genomics
Volume: 19, Issue: 4
Page: 300-312
Authors: Rabia Habib, Nighat Noureen* and Neha Nadeem

A Review on Synthesis of Benzothiazole Derivatives

Journal: Current Organocatalysis
Volume: 4, Issue: 3
Page: 164-181
Authors: Subhash Banerjee*, Soumen Payra and Arijit Saha

Neurodegenerative Disorders Treatment: The MicroRNA Role

Journal: Current Gene Therapy
Volume: 17, Issue: 5
Page: 327-363
Authors: Barbara Ridolfi and Hanin Abdel-Haq*

Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 16, Issue: 8
Page: 945-964
Authors: Javier Caballero-Villarraso, Alberto Galvan, Begona Maria Escribano and Isaac Tunez*

Targeting Astrocytes for Treatment in Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 33
Page: 5037-5044
Authors: Mina Peric, Dinko Mitrecic and Pavle R. Andjus*

Astrocytes Pathology in ALS: A Potential Therapeutic Target?

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 33
Page: 5022-5036
Authors: Sonja Johann*

Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 33
Page: 5010-5021
Authors: Mariana Pehar, Benjamin A. Harlan, Kelby M. Killoy and Marcelo R. Vargas*

Metallothionein is a Potential Therapeutic Strategy for Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 33
Page: 5001-5009
Authors: Shin-ichi Ono*

Interactions of VDAC with Proteins Involved in Neurodegenerative Aggregation: An Opportunity for Advancement on Therapeutic Molecules

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 40
Page: 4470-4487
Authors: Andrea Magri* and Angela Messina*

Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders

Journal: Current Drug Metabolism
Volume: 18, Issue: 9
Page: 786-797
Authors: Khanh Tu Nguyen, Minh Nguyet Pham, Toi Van Vo, Wei Duan, Phuong Ha-Lien Tran* and Thao Truong-Dinh Tran*

Environment and Neurodegenerative Diseases: An Update on miRNA Role

Journal: MicroRNA
Volume: 6, Issue: 3
Page: 157-165
Authors: Margherita Ferrante* and Gea Oliveri Conti

Small-molecule Modulation of HDAC6 Activity: The Propitious Therapeutic Strategy to Vanquish Neurodegenerative Disorders

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 37
Page: 4104-4120
Authors: Shabir A. Ganai*

Clinical Uses of Melatonin in Neurological Diseases and Mental and Behavioural Disorders

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 35
Page: 3851-3878
Authors: Emilio J. Sanchez-Barcelo*, Noemi Rueda, María D. Mediavilla , Carmen Martinez-Cue and Russel J. Reiter

Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview

Journal: Current Alzheimer Research
Volume: 14, Issue: 11
Page: 1190-1197
Authors: Khurshid Ahmad, Mohammad Hassan Baig*, Gohar Mushtaq, Mohammad Amjad Kamal, Nigel H. Greig and Inho Choi*

Neurotoxicity of Insecticides

Journal: Current Medicinal Chemistry
Volume: 24, Issue: 27
Page: 2988-3001
Authors: Julien Cassereau, Marc Ferré, Arnaud Chevrollier, Philippe Codron, Christophe Verny, Chadi Homedan, Guy Lenaers, Vincent Procaccio, Pascale May-Panloup and Pascal Reynier*

Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 5
Page: 693-730
Authors: Ivana Bjelobaba, Danijela Savic and Irena Lavrnja

New Therapeutics to Modulate Mitochondrial Function in Neurodegenerative Disorders

Journal: Current Pharmaceutical Design
Volume: 23, Issue: 5
Page: 731-752
Authors: Heather M. Wilkins and Jill K. Morris*

Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited

Journal: Current Medicinal Chemistry
Volume: 23, Issue: 42
Page: 4753-4772
Authors: Manuel J. Rodríguez and Nicole Mahy

Effectiveness of the Treatment with Botulinum Toxin Type A (BTX-A) in the Management of the Spasticity in Patients with Amyotrophic Lateral Sclerosis (ALS)

Journal: Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued)
Volume: 3, Issue: 1
Page: 73-77
Authors: Riccardo Marvulli, Marisa Megna, Ersilia Romanelli, Lucia Mastromauro, Elio Conte, Giulio Lancioni, Maria Dargenio, Grazia De Venuto, Giulia A. Gallo, Rosanna Lerario, Pietro Fiore and Giancarlo Ianieri

Current Therapy of Drugs in Amyotrophic Lateral Sclerosis

Journal: Current Neuropharmacology
Volume: 14, Issue: 4
Page: 314-321
Authors: Haiyan Lu, Wei Dong Le, Ya-Ying Xie and Xiao-Ping Wang

Modelling and Treating Amyotrophic Lateral Sclerosis through Induced- Pluripotent Stem Cells Technology

Journal: Current Stem Cell Research & Therapy
Volume: 11, Issue: 4
Page: 301-312
Authors: Delphine Bohl, Roland Pochet, Dinko Mitrecic and Charles Nicaise

Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis

Journal: Current Stem Cell Research & Therapy
Volume: 11, Issue: 1
Page: 41-50
Authors: Mahsa Hajivalili, Fatemeh Pourgholi, Hossein Samadi Kafil, Farhad Jadidi-Niaragh and Mehdi Yousefi

Astrocytes: New Targets for the Treatment of Neurodegenerative Diseases

Journal: Current Pharmaceutical Design
Volume: 21, Issue: 25
Page: 3570-3581
Authors: Charles Finsterwald, Pierre J. Magistretti and Sylvain Lengacher

Enhanced Action Potential Passage Through the Node of Ranvier of Myelinated Axons via Proton Hopping

Journal: Current Computer-Aided Drug Design
Volume: 11, Issue: 1
Page: 5-7
Authors: Lemont Kier, Lowell Hall and Robert M. Tombes

Recent Patents in Cell Therapy for Amyotrophic Lateral Sclerosis

Journal: Recent Patents on Regenerative Medicine (Discontinued)
Volume: 5, Issue: 1
Page: 10-19
Authors: Eithan D. Haim, Stephanie N. Williams, Paul R. Sanberg and Svitlana N. Garbuzova-Davis

Is Innate Immunity and Inflammasomes Involved in Pathogenesis of Amyotrophic Lateral Sclerosis (ALS)?

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Under Re-organization)
Volume: 9, Issue: 1
Page: 40-45
Authors: Caroline M.O.Volpe and José A. Nogueira-Machado

Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling

Journal: Current Medicinal Chemistry
Volume: 22, Issue: 17
Page: 2004-2021
Authors: Giovanna Morello, Francesca Luisa Conforti, Rosalba Parenti, Velia D’Agata and Sebastiano Cavallaro

Neurodegeneration in the Brain Tumor Microenvironment: Glutamate in the Limelight

Journal: Current Neuropharmacology
Volume: 13, Issue: 2
Page: 258-265
Authors: Nicolai E. Savaskan, Zheng Fan, Thomas Broggini, Michael Buchfelder and Ilker Y. Eyüpoglu

New Kid on the Block: Does Histamine Get Along with Inflammation in Amyotrophic Lateral Sclerosis?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 5
Page: 677-686
Authors: Cinzia Volonte, Chiara Parisi and Savina Apolloni

Modulation of Endoplasmic Reticulum Stress: An Opportunity to Prevent Neurodegeneration?

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 4
Page: 518-533
Authors: Ana I. Placido, Claudia M.F. Pereira, Ana I. Duarte, Emanuel Candeias, Sonia C. Correia, Cristina Carvalho, Susana Cardoso, Catarina R. Oliveira and Paula I. Moreira

Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule

Journal: Current Gene Therapy
Volume: 15, Issue: 3
Page: 266-276
Authors: Rustem Robertovich Islamov, Albert Anatolyevich Rizvanov, Marat Alexandrovich Mukhamedyarov, Ilnur Ildusovich Salafutdinov, Ekaterina Evgenevna Garanina, Valeria Yuryevna Fedotova, Valeria Vladimirovna Solovyeva, Yana Olegovna Mukhamedshina, Zufar Zufarovich Safiullov, Andrey Alexandrovich Izmailov, Daria Sergeevna Guseva, Andrey Lvovich Zefirov, Andrey Pavlovich Kiyasov and Andras Palotas

MicroRNAs: Newcomers into the ALS Picture

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 2
Page: 194-207
Authors: Cinzia Volonte, Savina Apolloni and Chiara Parisi

Interferon-γ-Induced Neurotoxicity of Human Astrocytes

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14, Issue: 2
Page: 251-256
Authors: Sadayuki Hashioka, Edith G. McGeer, Tsuyoshi Miyaoka, Rei Wake, Jun Horiguchi and Patrick L. McGeer

Natural Compounds Used as Therapies Targeting to Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Biotechnology
Volume: 16, Issue: 3
Page: 211-218
Authors: Seyed F. Nabavi, Maria Daglia, Giuseppe D’Antona, Eduardo Sobarzo-Sanchez, Zeliha S. Talas and Seyed M. Nabavi

Amyotrophic Lateral Sclerosis: A Genetic Point of View

Journal: Current Molecular Medicine
Volume: 14, Issue: 8
Page: 1089-1101
Authors: C. Carlesi, E. Caldarazzo Ienco, M. Mancuso and G. Siciliano

The Glutamate Hypothesis in ALS: Pathophysiology and Drug Development

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 31
Page: 3551-3575
Authors: H. Blasco, S. Mavel, P. Corcia and P.H. Gordon

Editorial (Thematic Issue: Emerging Biomarkers for Drug Development in Amyotrophic Lateral Sclerosis)

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 31
Page: 3507-3507
Authors: Sebastiano Cavallaro

Biomarkers and Future Targets for Development in Amyotrophic Lateral Sclerosis

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 31
Page: 3535-3550
Authors: Parvathi Menon, Matthew C. Kiernan and Steve Vucic

Potential Therapeutic Drugs and Methods for the Treatment of Amyotrophic Lateral Sclerosis

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 31
Page: 3583-3593
Authors: G. Yacila and Y. Sari

Therapeutic Targeting of Epigenetic Components in Amyotrophic Lateral Sclerosis (ALS)

Journal: Current Medicinal Chemistry
Volume: 21, Issue: 31
Page: 3576-3582
Authors: J. Lee, H. Ryu, G. Keum, Y.J. Yoon, N.W. Kowall and H. Ryu

SLC1 Glutamate Transporters and Diseases: Psychiatric Diseases and Pathological Pain

Journal: Current Molecular Pharmacology
Volume: 6, Issue: 2
Page: 66-73
Authors: Takayuki Nakagawa and Shuji Kaneko

Mitochondrial Fusion and Fission Proteins Expression Dynamically Change in a Murine Model of Amyotrophic Lateral Sclerosis

Journal: Current Neurovascular Research
Volume: 10, Issue: 3
Page: 222-230
Authors: Wentao Liu, Toru Yamashita, Fengfeng Tian, Nobutoshi Morimoto, Yoshio Ikeda, Kentaro Deguchi and Koji Abe

A New Interpretative Paradigm for Conformational Protein Diseases

Journal: Current Protein & Peptide Science
Volume: 14, Issue: 2
Page: 141-160
Authors: Luigi Francesco Agnati, Diego Guidolin, Amina S. Woods, Francisco Ciruela, Chiara Carone, Annamaria Vallelunga, Dasiel Oscar Borroto Escuela, Susanna Genedani and Kjell Fuxe

Defects in RNA Metabolism links FTD and ALS Pathogenesis: TDP-43, FUS, and C9orf72

Journal: Current Enzyme Inhibition
Volume: 9, Issue: 1
Page: 28-40
Authors: Qiudong Deng, Termpanit Chalermpalanupap and Thomas Kukar

Vascular Endothelial Growth Factor Electro-Gene Therapy Improves Functional Outcome in a Mouse Model of ALS

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Under Re-organization)
Volume: 13, Issue: 2
Page: 107-111
Authors: Tatsufumi Murakami, Yuki Shimada, Yoshimi Imada, Akihiro Nakamura and Yoshihide Sunada

SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status

Journal: Current Topics in Medicinal Chemistry
Volume: 12, Issue: 22
Page: 2560-2572
Authors: Yuewei Sheng, Madhuri Chattopadhyay, Julian Whitelegge and Joan Selverstone Valentine

X-ray Crystallography and Computational Docking for the Detection and Development of Protein–Ligand Interactions

Journal: Current Medicinal Chemistry
Volume: 20, Issue: 4
Page: 569-575
Authors: N.M. Kershaw, G.S.A. Wright, R. Sharma, S.V. Antonyuk, R.W. Strange, N.G. Berry, P.M. O'Neill and S.S. Hasnain

Molecular Biomarkers for Amyotrophic Lateral Sclerosis

Journal: Current Bioinformatics
Volume: 8, Issue: 1
Page: 87-92
Authors: Chi-Shin Hwang, Chia-Hung Hsieh, Guan-Ting Liu, Si-Yi Chen, Johnannes Scheng-Ming Tschen and Hao-Teng Chang

Amyotrophic Lateral Sclerosis Treatment with Ultramicronized Palmitoylethanolamide: A Case Report

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 11, Issue: 7
Page: 933-936
Authors: Simonetta Clemente

Single-dose Pharmacokinetics and Tolerability of Oral Delta-9- Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis

Journal: Drug Metabolism Letters
Volume: 6, Issue: 2
Page: 102-108
Authors: Markus Joerger, Justin Wilkins, Stefania Fagagnini, Reto Baldinger, Rudolf Brenneisen, Ursula Schneider, Bea Goldman and Markus Weber

Biomarkers in Amyotrophic Lateral Sclerosis: Is There A Neurovascular Pathway?

Journal: Current Neurovascular Research
Volume: 9, Issue: 4
Page: 302-309
Authors: Himshikha Bhutani and Akshay Anand

Identification of Pharmacological Targets in Amyotrophic Lateral Sclerosis Through Genomic Analysis of Deregulated Genes and Pathways

Journal: Current Genomics
Volume: 13, Issue: 4
Page: 321-333
Authors: Sabrina Paratore, Salvatore Pezzino and Sebastiano Cavallaro

Ultrasound-Induced Blood-Brain Barrier Opening

Journal: Current Pharmaceutical Biotechnology
Volume: 13, Issue: 7
Page: 1332-1345
Authors: Elisa E. Konofagou, Yao-Sheng Tunga, James Choia, Thomas Deffieuxa, Babak Baseria and Fotios Vlachosa

Neuroprotection for Amyotrophic Lateral Sclerosis: Role of Stem Cells, Growth Factors, and Gene Therapy

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12, Issue: 1
Page: 15-27
Authors: Rachna S. Pandya, Lilly L. J. Mao, Edward W. Zhou, Robert Bowser, Zhenglun Zhu, Yongjin Zhu and Xin Wang

ER Stress and UPR in Familial Amyotrophic Lateral Sclerosis

Journal: Current Molecular Medicine
Volume: 6, Issue: 1
Page: 79-86
Authors: Bradley J. Turner and Julie D. Atkin

Neurotrophic Factors - A Tool for Therapeutic Strategies in Neurological,Neuropsychiatric and Neuroimmunological Diseases?

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 22
Page: 2318-2329
Authors: O. Schulte-Herbruggen, A. Braun, S. Rochlitzer, M. C. Jockers-Scherubl and R. Hellweg

Possible Neuroprotective Strategies in ALS

Journal: Current Neuropharmacology
Volume: 2, Issue: 3
Page: 323-329
Authors: Simone Beretta, Laura Brighina and Carlo Ferrarese

Chemical and Pharmacological Aspects of Heteroaryl-Nitrones

Journal: Current Medicinal Chemistry
Volume: 7, Issue: 12
Page: 1255-1267
Authors: Solo Goldstein and Pierre Lestage

Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?

Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 6, Issue: 4
Page: 258-271
Authors: E. Conti, M. B. Musumeci, G. Egidy Assenza, G. Quarta, C. Autore and M. Volpe

RNAi Applications in Therapy Development for Neurodegenerative Disease

Journal: Current Pharmaceutical Design
Volume: 15, Issue: 34
Page: 3977-3991
Authors: M. M. Maxwell

Current Nervous System Related Drug Targets for the Treatment of Amyotrophic Lateral Sclerosis

Journal: Current Pharmaceutical Design
Volume: 16, Issue: 18
Page: 2053-2073
Authors: Aaron C. Pawlyk, Joel A. Cassel and Allen B. Reitz

The Potential Role of Glycogen Synthase Kinase 3 Inhibitors as Amyotrophic Lateral Sclerosis Pharmacological Therapy

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 20
Page: 3028-3034
Authors: V. Palomo, D. I. Perez, C. Gil and A. Martinez

Amyotrophic Lateral Sclerosis: From Research to Therapeutic Attempts and Therapeutic Perspectives

Journal: Current Medicinal Chemistry
Volume: 18, Issue: 36
Page: 5655-5665
Authors: A. Contestabile

Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Other Anti- Inflammatory Agents in the Treatment of Neurodegenerative Disease

Journal: Current Alzheimer Research
Volume: 2, Issue: 3
Page: 355-365
Authors: Andis Klegeris and Patrick L. McGeer

P-gp Transporter and its Role in Neurodegenerative Diseases

Journal: Current Topics in Medicinal Chemistry
Volume: 9, Issue: 2
Page: 209-217
Authors: Simona Rapposelli, Maria Digiacomo and Aldo Balsamo

The Therapeutic Potential of Stem Cells in Amyotrophic Lateral Sclerosis

Journal: Current Signal Transduction Therapy
Volume: 6, Issue: 3
Page: 341-346
Authors: Dinko Mitrecic, Charles Nicaise, Srecko Gajovic and Roland Pochet

Selegiline (l-Deprenyl) as a Unique Neuroprotective Agent for Chronic Neurodegenerative Disorders- A Lesson from MAO Inhibition

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 4, Issue: 4
Page: 255-267
Authors: Ruey-Meei Wu, Dennis L. Murphy and Chuang C. Chiueh

Molecular Insights and Therapeutic Targets in Amyotrophic Lateral Sclerosis

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 7, Issue: 1
Page: 11-19
Authors: Ammar Al-Chalabi and Vineeta B. Tripathi

Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9, Issue: 3
Page: 285-296
Authors: N. Ticozzi, A. Ratti and V. Silani

The Mammalian Tachykinin Ligand-Receptor System: An Emerging Target for Central Neurological Disorders

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9, Issue: 5
Page: 627-635
Authors: Nick Pantaleo, Wayne Chadwick, Sung-Soo Park, Liyun Wang, Yu Zhou, Bronwen Martin and Stuart Maudsley

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10, Issue: 3
Page: 391-403
Authors: Kathryn A. Frankola, Nigel H. Greig, Weiming Luo and David Tweedie

The ASK1-MAP Kinase Signaling in ER Stress and Neurodegenerative Diseases

Journal: Current Molecular Medicine
Volume: 6, Issue: 1
Page: 87-97
Authors: Yusuke Sekine, Kohsuke Takeda and Hidenori Ichijo

Timing is Everything

Journal: Current Neurovascular Research
Volume: 2, Issue: 5
Page: 363-364
Authors: Kenneth Maiese

Non-Primate EIAV-Based Lentiviral Vectors as Gene Delivery System for Motor Neuron Diseases

Journal: Current Gene Therapy
Volume: 4, Issue: 3
Page: 277-286
Authors: M. Azzouz and N. Mazarakis

The Heterogeneity of Amyotrophic Lateral Sclerosis: A Possible Explanation of Treatment Failure

Journal: Current Medicinal Chemistry
Volume: 14, Issue: 30
Page: 3185-3200
Authors: Ettore Beghi, Tiziana Mennini, Caterina Bendotti, Paolo Bigini, Giancarlo Logroscino, Adriano Chio, Orla Hardiman, Douglas Mitchell, Robert Swingler, Bryan J. Traynor and Ammar Al-Chalabi

Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders

Journal: Current Gene Therapy
Volume: 8, Issue: 6
Page: 461-473
Authors: Cecilia Lundberg, Tomas Bjorklund, Thomas Carlsson, Johan Jakobsson, Philippe Hantraye, Nicole Deglon and Deniz Kirik

AAV as a Gene Transfer Vector for the Treatment of Neurological Disorders: Novel Treatment Thoughts for ALS

Journal: Current Gene Therapy
Volume: 9, Issue: 5
Page: 428-433
Authors: Mark E. Hester, Kevin D. Foust, Rita W. Kaspar and Brian K. Kaspar

Huntingtons Disease: The Value of Transcranial Meganetic Stimulation

Journal: Current Medicinal Chemistry
Volume: 17, Issue: 23
Page: 2482-2491
Authors: F.J. Medina and I. Tunez

Pathogens and Chronic or Long-Term Neurologic Disorders

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 11, Issue: 1
Page: 40-52
Authors: Ioannis Starakis, George Panos, Angelos Koutras and Elias E. Mazokopakis

Impact and Therapeutic Potential of PPARs in Alzheimers Disease

Journal: Current Neuropharmacology
Volume: 9, Issue: 4
Page: 643-650
Authors: Michael T. Heneka, Elisabet Reyes-Irisarri, Michael Hull and Markus P. Kummer

Increased Susceptibility to Plasma Lipid Peroxidation in Alzheimer Disease Patients

Journal: Current Alzheimer Research
Volume: 1, Issue: 2
Page: 103-109
Authors: Carmen Galbusera, Maurizio Facheris, Fulvio Magni, Gloria Galimberti, Gessica Sala, Lucia Tremolada, Valeria Isella, Franca Rosa Guerini, Ildebrando Appollonio, Marzia Galli-Kienle and Carlo Ferrarese

Recent Advances in the Treatment of Amyotrophic Lateral Sclerosis. Emphasis on Kynurenine Pathway Inhibitors

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 9, Issue: 1
Page: 32-39
Authors: Yiquan Chen, Vincent Meininger and Gilles J. Guillemin

Crosstalk Between Calpain and Calcineurin in Excitotoxic Neurodegeneration; Therapeutic Targets for the Treatment of Excitotoxic Neurodegeneration

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 5, Issue: 3
Page: 207-216
Authors: Hai-Yan Wu, Hideki Matsui and Kazuhito Tomizawa